Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistanceIrina Kareva, Giannoula Klement|Cancer Letters|2014Cited by 254
Identifying key questions in the ecology and evolution of cancerAntoine M. Dujon, Beáta Újvári, Catherine Alix‐Panabières et al.|Evolutionary Applications|2020Cited by 98
Predator-Prey in Tumor-Immune Interactions: A Wrong Model or Just an Incomplete One?Irina Kareva, Joel S. Brown|Frontiers in Immunology|2021Cited by 50